Answers are grounded in this paper and cite their sources.
Review examines transcatheter patent ductus arteriosus closure in extremely low birth weight infants, highlighting an emerging alternative to medical therapy and surgery.
Clinically significant patent ductus arteriosus (PDA) has been associated with significant morbidity in extremely low birth weight (ELBW) infants. Current management of ELBW infants with hemodynamically significant PDA includes supportive treatment, pharmacological therapy, and surgical ligation. All of these therapeutic options have their advantages and limitations. More recently, transcatheter PDA closure has been described as a viable option in this population. In this paper, we provide a comprehensive review of this emerging procedure.
No takes yet. Share an insight, caveat, or question.
Almeida-Jones et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: